Sparta, Lexin Pharmaceutical Corp. deal

The companies reached a purchase agreement under which SPTAC will acquire Lexin for up to 2.6 million SPTAC shares (see BioCentury Jan. 22). SPTAC has 6.2 million shares outstanding prior to the acqui...